Distribution of Mediastinal Lesions Across Multi-Institutional, International, Radiology Databases

Distribution of Mediastinal Lesions Across Multi-Institutional, International, Radiology Databases

Journal Pre-proof The Distribution of Mediastinal Lesions across Multi-Institutional, International, Radiology Databases Anja C. Roden, MD, Wentao Fan...

12MB Sizes 0 Downloads 22 Views

Journal Pre-proof The Distribution of Mediastinal Lesions across Multi-Institutional, International, Radiology Databases Anja C. Roden, MD, Wentao Fang, MD, Shen Yan, MD, Brett W. Carter, MD, Darin B. White, MD, Sarah M. Jenkins, MS, Grant M. Spears, Julian R. Molina, MD, PhD, Eyal Klang, MD, Mattia Di Segni, Jeanne B. Ackman, MD, Edward Z. Sanchez, MD, Nicolas Girard, MD, PhD, Engjellush Shumeri, MSc, Marie-Pierre Revel, MD, Guillaume Chassagnon, MD, Ami Rubinowitz, MD, Demetrius Dicks, MD, Frank Detterbeck, MD, Jane P. Ko, MD, Conrad Falkson, MBChB, Samantha Sigurdson, MD, Sabrina Segreto, MD, Silvana Del Vecchio, MD, Giovanella Pamieri, MD, Margaret Ottaviano, MD, Mirella Marino, MD, Robert Korst, MD, Edith M. Marom, MD PII:

S1556-0864(19)33848-1

DOI:

https://doi.org/10.1016/j.jtho.2019.12.108

Reference:

JTHO 1669

To appear in:

Journal of Thoracic Oncology

Received Date: 6 October 2019 Revised Date:

27 November 2019

Accepted Date: 3 December 2019

Please cite this article as: Roden AC, Fang W, Yan S, Carter BW, White DB, Jenkins SM, Spears GM, Molina JR, Klang E, Di Segni M, Ackman JB, Sanchez EZ, Girard N, Shumeri E, Revel M-P, Chassagnon G, Rubinowitz A, Dicks D, Detterbeck F, Ko JP, Falkson C, Sigurdson S, Segreto S, Del Vecchio S, Pamieri G, Ottaviano M, Marino M, Korst R, Marom EM, The Distribution of Mediastinal Lesions across Multi-Institutional, International, Radiology Databases, Journal of Thoracic Oncology (2020), doi: https://doi.org/10.1016/j.jtho.2019.12.108. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

© 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

1

Title: The Distribution of Mediastinal Lesions across Multi-Institutional, International,

2

Radiology Databases

3

Authors: Anja C. Roden, MD1, Wentao Fang, MD2, Shen Yan, MD3, Brett W. Carter, MD4,

4

Darin B. White, MD5, Sarah M. Jenkins, MS6, Grant M. Spears6, Julian R. Molina, MD, PhD7,

5

Eyal Klang, MD8, Mattia Di Segni8, Jeanne B. Ackman, MD9, Edward Z. Sanchez, MD9, Nicolas

6

Girard, MD, PhD10, Engjellush Shumeri, MSc10, Marie-Pierre Revel, MD11, Guillaume

7

Chassagnon MD11, Ami Rubinowitz, MD12, Demetrius Dicks, MD12, Frank Detterbeck, MD13,

8

Jane P. Ko, MD14, Conrad Falkson, MBChB15, Samantha Sigurdson, MD15, Sabrina Segreto,

9

MD16, Silvana Del Vecchio, MD16, Giovanella Pamieri, MD17, Margaret Ottaviano, MD17,

10

Mirella Marino, MD18, Robert Korst, MD19, Edith M. Marom, MD8

11

1

Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, MN, USA

12

2

Department of Thoracic Surgery, Shanghai Chest Hospital, Jiaotong University Medical School,

13

China

14

3

Department of Radiology, Shanghai Chest Hospital, Jiaotong University Medical School, China

15

4

Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center,

16

Houston, Texas, USA

17

5

Department of Radiology, Mayo Clinic Rochester, MN, USA

18

6

Department of Health Sciences Research, Mayo Clinic Rochester, MN, USA

19

7

Division of Medical Oncology, Department of Oncology; Mayo Clinic Rochester, MN, USA

20

8

The Chaim Sheba Medical Center, affiliated with the Tel Aviv University, Tel Aviv, Israel

21

9

Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston,

22

MA, USA

23

10

Curie Montsouris Thorax Institute, Institute Curie, Paris, France

24

11

25

12

26

USA

27

13

Section of Thoracic Surgery, Yale University School of Medicine, New Haven, CT, USA

28

14

NYU Langone Health, NYU School of Medicine, USA

29

15

30

16

31

17

32

Naples, Naples, Italy

33

18

Department of Pathology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.

34

19

Department of Thoracic Surgery, Mount Sinai Health System, Icahn School of Medicine at

35

Mount Sinai, New York, NY; Valley/Mount Sinai Comprehensive Cancer Care, Paramus, NJ;

36

Department of Surgery, The Valley Hospital, Ridgewood, NJ, USA

Radiology Department, Cochin hospital, University of Paris, Paris, France Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT,

CCSEO and Queen’s University, Kingston, Canada Department of Advanced Biomedical Sciences. University Federico II Naples, Italy

Rare Tumours Reference Center of Campania Region (CRTR), University Federico II of

37 38

Running Title: Distribution of mediastinal lesions

39

Conflict of Interest Statement

40

No author has a financial conflict of interest. No funding sources to disclose.

41 42

Corresponding Author:

Anja C. Roden, MD

43

Department of Laboratory Medicine & Pathology

44

Mayo Clinic Rochester

45

Hilton 11

46

200 First St SW, Rochester MN, 55905

47

Tel.:

507-284-1192

48

Fax:

507-266-3771

49

Email: [email protected]

50 51 52

Drs. Anja C. Roden and Wentao Fang contributed equally to the study.

Abstract

53 54

Background

55

Mediastinal lesions are uncommon; studies on their distribution are in general small and

56

from a single institution. Furthermore, these studies are usually based on pathology or surgical

57

databases and therefore miss many lesions that are not biopsied and/or resected. Our aim was to

58

identify the distribution of lesions in the mediastinum in a large international, multi-institutional

59

cohort.

60

Material and Methods

61

At each participating institution, a standardized retrospective radiology database search

62

for interpretations of CT, PET-CT and MRI scans including any of the following terms:

63

“mediastinal nodule”, “mediastinal lesion”, “mediastinal mass” or “mediastinal abnormality”

64

was performed (2011-2014). Standardized data were collected. Statistical analysis was

65

performed.

66

Results

67

Amongst 3,308 cases, thymomas (27.8%), benign mediastinal cysts (20.0%) and

68

lymphomas (16.1%) were most common. The distribution of lesions varied amongst mediastinal

69

compartments; thymomas (38.3%), benign cysts (16.8%) and neurogenic tumors (53.9%) were

70

the most common lesions in the prevascular, visceral and paravertebral mediastinum,

71

respectively (p<0.001). Mediastinal compartment was associated with age; patients with

72

paravertebral lesions were the youngest (p<0.0001). Mediastinal lesions differed by

73

continent/country with benign cysts being the most common mediastinal lesions in China,

74

thymomas in Europe and lymphomas in North America and Israel (p<0.001). Benign cysts,

75

thymic carcinomas, and metastases were more commonly seen in larger hospitals, while

76

lymphomas and thymic hyperplasia occurred more often in smaller hospitals (p<0.01).

77

Conclusions

78

Our study confirmed that spectrum and frequency of mediastinal lesions depends on

79

mediastinal compartment and age. This information provides helpful demographic data and is

80

important when considering the differential diagnosis of a mediastinal lesion.

81 82 83

84

Introduction

85

Lesions of the mediastinum are rare. There have been three large imaging studies,

86

population-based cohort studies[1, 2] and a lung cancer screening study[3] which have found the

87

prevalence of mediastinal lesions to be 0.73% to 0.9%. However, the overall prevalence of

88

mediastinal lesions in an unselected population and their distribution in specific mediastinal

89

compartments are difficult to ascertain from the medical literature for various reasons.[4] First,

90

reported series usually include a defined population as they are performed for other purposes.

91

For instance the main purpose of the computed tomography (CT) imaging study by Henschke et

92

al[3] was to screen patients for lung cancer who were between 40 and 92 years old with a history

93

of 1 to 267 pack-years smoking. In the Framingham Heart Study by Araki et al[1], second and

94

third generations from the original Framingham population that were comprised of patients

95

between 30 and 62 years old and who lived in Framingham, MA, USA underwent CT scanning

96

to identify risk factors for heart disease. Second, most studies tend to include only surgically

97

resected or biopsied lesions; however, some benign lesions are never resected or even biopsied.

98

Thus, the inclusion of non-neoplastic lesions such as thymic and pericardial cysts varies between

99

series.[5-11] Third, studies tend to be centered on a single institution’s experience, which might

100

be an academic institution or a tertiary hospital, thereby introducing referral bias. In addition,

101

many series are rather small, with less than 400 cases. Fourth, there is variability in the inclusion

102

of lymphomas. While it has been previously reported that 50% of Hodgkin lymphomas (HL) and

103

20% of Non-Hodgkin lymphomas (NHL) involve the mediastinum[12], only approximately 3%

104

of HL and 6% of NHL reportedly arise as primary mediastinal malignancies.[13-15]. Finally yet

105

importantly, many of the studies on the prevalence and distribution of mediastinal lesions are

106

over 20 years old. However, the increased patient referral for imaging studies for various

107

indications and advances in imaging techniques have greatly improved the diagnostic

108

capabilities, warranting the reappraisal of the distribution of mediastinal lesions.

109

The International Thymic Malignancy Interest Group (ITMIG) started an initiative to

110

study mediastinal lesions other than thymic epithelial tumors. One of ITMIG’s goals was to

111

identify the overall frequency of different mediastinal lesions. To avoid bias introduced by

112

pathology or surgical databases that only collect cases from which tissue was recovered,

113

institutional radiology databases were explored. The aim of our study was to obtain a better

114

understanding of the frequency of solitary primary mediastinal lesions and their typical location

115

within the mediastinum and to assess if this frequency differs between geographic location

116

and/or size of the hospital, based on a search of radiology databases across multiple international

117

institutions.

118 119 120

Materials and Methods Each of the participating institutions (Table 1) conducted a standardized retrospective

121

search of their radiology database for CT, positron-emission tomography-CT (PET-CT) and

122

magnetic resonance imaging (MRI) scan interpretations performed between January 1, 2011 and

123

December 31, 2014. The search included either one of the following terms: “mediastinal

124

nodule”, “mediastinal lesion”, “mediastinal mass” or “mediastinal abnormality”. All authors

125

confirmed that only these 4 search terms were used. These terms were identified during a pilot

126

study that included four institutions (Mayo Clinic Rochester, MD Anderson Cancer Center,

127

Sheba Medical Center, Shanghai Chest Hospital) and that aimed to define optimal search criteria.

128

Because this study was carried out by investigators at multiple different institutions, the search

129

software varied and therefore no central investigator training could be carried out. The study

130

was not set up to perform search and analysis of reports independently and a sample was also not

131

tested twice.

132 133 134 135 136

The study was performed in accordance with institutional policies for the use of existing medical information for research and was approved by all local Institutional Review Boards. For subset analysis, participating institutions were categorized by size according to the number of beds (300-600, > 600). The date of the first reference of the solitary mediastinal lesion was recorded. Medical

137

records were searched for a final pathology diagnosis, date of initial scan mentioning the lesion,

138

and date of last imaging follow-up, the latter could be after December 31, 2014.

139

Based upon review of the chest CT, MRI or PET-CT report and/or images, the following

140

data were collected: (1) date of initial imaging showing the mediastinal abnormality; (2) imaging

141

modality which showed the mediastinal lesion (CT, MRI or PET-CT); (3) mediastinal

142

compartment in which the epicenter of the abnormality resided in; (4) time of follow-up of the

143

patient from first to last imaging exam; (5) diagnosis by imaging if the mass was not assessed by

144

pathology; and (6) pathology diagnosis if available. Only new diagnoses were included;

145

recurrences or duplications were excluded. The latest follow up date was June 30, 2016. While

146

lymphomas were included in the study, only primary mediastinal lymphomas that presented as a

147

solitary mediastinal lesion were considered. Patients who had mediastinal involvement by

148

systemic lymphoma and/or multiple lesions were excluded. Data on tissue sampling techniques

149

such as fine needle aspiration, core biopsy, or surgical resection were not collected. The

150

mediastinum was divided according to the ITMIG classification into prevascular, visceral, and

151

paravertebral compartments as summarized in Supplemental Table 1.[16]

152

The study population included all patients ages 18 years and older. Data on age and

153

gender were also collected. Smoking status was not noted. De-identified data were centrally

154

collected and analyzed.

155

In an attempt to identify differences in the distribution of mediastinal lesions based on

156

geographic areas, the results were combined from hospitals that were from the same continent

157

including Asia, Europe and North America, recognizing that this distribution does not entirely

158

reflect ethnicity and likely is biased by type of institution. Given the large variation in number of

159

cases contributed from the 2 hospitals in Asia, cases from China and Israel were analyzed

160

separately.

161

Data was summarized with frequencies and percentages or with medians, interquartile

162

ranges and ranges (as appropriate). Patient and lesion characteristics were compared by

163

compartment (prevascular vs visceral vs paravertebral), geographic region (China vs Israel vs

164

Europe vs North America), size of hospital (300-600 beds vs > 600 beds), age category (18-29,

165

30-39, 40-49, 50-59, 60-69, ≥ 70) and gender using Kruskal-Wallis tests for age, and Fisher’s

166

exact tests, or chi-square tests for the remaining categorical characteristics. P-values less than

167

0.05 were considered statistically significant. All analyses were performed using SAS version

168

9.4 (SAS Institute Inc., Cary, NC).

169 170 171

Results A total of 3,504 patients with a newly identified mediastinal lesion on CT, PET-CT or

172

MRI scans were identified through the multi-institutional, international database search. Of these

173

patients 196 were excluded because of lack of follow-up imaging and/or pathology. Therefore,

174

3,308 patients were available for the study. Patient demographics are summarized in Table 1.

175

Most lesions were identified by CT scan (Table 1). In approximately two-thirds of patients a

176

pathology diagnosis was available (Table 1), whereas the remainder had typical imaging findings

177

for diagnosis with imaging follow-up for confirmation.

178

Results of Pilot Study

179

To identify optimal search terms two separate pilot searches were performed on radiology

180

databases at 4 institutions. One pilot search (broad search criteria) included the following terms:

181

“mediastinal mass”, “mediastinal process”, “mediastinal abnormality”; and cases with a phrase

182

“no mediastinal mass” were excluded. CT, PET/CT and MRI studies were included. This search

183

yielded 421 (Mayo Clinic Rochester, 2012-2015), 3998 (Shanghai Chest Hospital, 2006-2015),

184

1484 (MD Anderson, 2012-2015) and 212 (Chaim Sheba, 2012-2015) cases. Between 20 and 27

185

cases were reviewed in each hospital to note possible key words; results are summarized in

186

Supplemental Table 2. The other pilot search (refined search criteria) was only performed at

187

Mayo Clinic Rochester using specific search terms such as “thymoma”, “thymic carcinoma”,

188

“thymolipoma”, “thymic cyst”, “germ cell tumor”, “teratoma”, “lymphangioma”, “parathyroid

189

adenoma”, “thyroid goiter”, “pericardial cyst”, “lymphoma”, “metastasis”, “esophageal cancer”,

190

“foregut cyst”, “duplication cyst”, “bronchogenic cyst”, “neurogenic tumor”, “schwannoma”,

191

“neurofibroma”, “ganglioneuroma”, “ganglioneuroblastoma”, “neuroblastoma”, “neurenteric

192

cyst”, “lateral thoracic meningocele”, “sclerosing mediastinitis”, “hemangioma”, and

193

“amyloidosis”. This search generated over 60,000 entries in 2015. This large number of cases

194

occurred because many of these lesions can occur in various organs, not only in the

195

mediastinum. While the use of the refined search criteria might have been more accurate, it was

196

felt that this approach would not have been feasible. Therefore, it was decided to use a variation

197

of the broad search criteria for the final analysis.

198

In addition a search of a pathology database was performed at Mayo Clinic Rochester

199

(1995-2014) using the following search terms: “thymus”, “mediastinum”, “vertebra”, and

200

“spine”. This search identified 3,540 (thymus, mediastinum) and 5,182 (vertebra, spine) lesions.

201

Four hundred-seventy cases were reviewed of each category. The results (after exclusion of

202

metastases and duplicates) are summarized in Supplemental Table 3.

203 204 205

Overall Frequency of Different Lesions in the Mediastinum The frequency of mediastinal lesions is summarized in Table 1 and illustrated in Figure

206

1A. The entire data are tabulated in Supplemental Table 4. The most common lesions in the

207

mediastinum included thymoma, which together with thymic carcinoma constituted 27.8% of

208

mediastinal lesions, benign cysts (20.0%) and lymphomas (16.1%).

209 210

Occurrence of Mediastinal Lesions Based on Mediastinal Compartment

211

Most lesions were found to reside within a single mediastinal compartment, with the

212

prevascular mediastinum being the most common site (69.8%) followed by the visceral and

213

paravertebral mediastinum (13.5% and 5.4%, respectively) (Table 1). In 370 (11.2%) patients,

214

the epicenter of the lesion could not be assessed with certainty. In these patients the lesions were

215

attributed to multiple compartments. The majority of the lesions identified in more than 1

216

compartment involved both the prevascular and the visceral compartment (299 of 370) followed

217

by lesions in the visceral and paravertebral (N=48), prevascular, visceral and paravertebral

218

(N=18) and prevascular and paravertebral (N=5) compartments. The frequency of mediastinal

219

lesions based on mediastinal compartment is summarized in Table 1 and Supplement 1. In the

220

prevascular mediastinum, thymomas (30.8%) (Figures 1A and 2A & B) were the most common

221

lesions, followed by benign cysts (24.0%) and lymphomas (14.4%). In contrast, in the visceral

222

mediastinum, benign cysts (16.8%) were the predominant lesions (Figure 2C) followed by

223

metastasis (14.8%) and benign thyroid lesions (13.0%). In the paravertebral mediastinum,

224

neurogenic tumors (53.9%) (Figure 2D) were the most often identified lesions, followed by

225

benign cysts (13.9%) and lymphomas (5%).

226

Demographics of Patients Based on Location of Mediastinal Lesion

227

Patient age and gender, based on location of the mediastinal lesion, are summarized in

228

Tables 1 and 2 and Figure 1C. The mediastinal compartment in which a lesion was identified

229

was associated with the age of the patient (p<0.0001) (Table 1). Patients with lesions in the

230

paravertebral compartment were the youngest (median age, 50 years old) while patients with

231

visceral mediastinal lesions were the oldest (median age, 60 years old). In contrast, there was no

232

difference in gender amongst different locations of lesions in the mediastinum.

233

Patient age was also associated with the diagnosis (Table 2). For instance, thymomas,

234

thymic carcinomas and benign cysts were most common in the age ranges of 50 to 59 and 60 to

235

69, while lymphomas and germ cell tumors were most frequently found in patients between 18

236

and 29 years old.

237

Distribution of Mediastinal Lesions Based on Geographic Region of the Hospital

238

Results of the distribution of mediastinal lesions based on geographic region are

239

summarized in Table 3 and illustrated in Figure 1B. While benign cysts were more common in

240

the group from China (35.5%), followed by thymomas and thymic carcinomas, lymphomas were

241

more common in Israel (24.1%), followed by metastases and thymomas. Metastases were overall

242

most commonly identified in cases from Israel (18.4% of all cases from Israel) (p<0.0001).

243

Cases from Europe were most commonly thymomas (22.8%), followed by lymphomas and

244

benign cysts. In North America, lymphomas were most common (25.5%), followed by

245

thymomas and benign cysts.

246

Frequency of Mediastinal Lesions Based on Size of the Hospital

247

The frequencies of mediastinal lesions based on size of the hospital are summarized in

248

Table 4. The majority of cases were contributed from larger hospitals with more than 600 beds.

249

None of the participating institutions had less than 300 beds. Relative numbers of paravertebral

250

lesions differed depending on the size of the hospital. Benign cysts, thymic carcinomas, and

251

metastases were more commonly seen in larger hospitals, while lymphomas and thymic

252

hyperplasia were found more frequently in smaller hospitals. There was no difference in the

253

relative number of patients with thymomas, neurogenic tumors, germ cell tumors, benign thyroid

254

lesions and small cell carcinomas depending on the hospital size.

255

There were significant differences between the imaging modality that was used to

256

identify the mediastinal lesion between large and smaller hospitals. Most imaging was performed

257

with CT scans. MRI and PET-CT were more frequently used in larger hospitals (4.8% and 3.1%,

258

respectively) than in smaller hospitals (1.8% and 1.2%, respectively).

259 260 261

Discussion In an international, multi-institutional study of solitary mediastinal lesions that were

262

newly identified by CT, PET-CT and/or MRI and collected over a 4-year time period by

263

radiology databases, we found that thymic epithelial malignancies (thymomas and thymic

264

carcinomas) are the most common mediastinal lesions (27.8%), followed by benign cysts

265

(20.0%), primary mediastinal lymphomas (16.1%) and metastases (5.1%). Furthermore we

266

showed that mediastinal lesions occur in the prevascular compartment most commonly, followed

267

by the visceral compartment. Thymomas were also the most common lesions in the prevascular

268

mediastinum in our study (30.8%), while benign cysts (16.8%) and neurogenic tumors (53.9%)

269

were the most commonly identified lesions in the visceral and paravertebral mediastinum,

270

respectively.

271

Our study has clinical implications, specifically because it was imaging-based and open

272

to all adult patients with any available cross-sectional chest imaging. The distribution of the

273

different mediastinal lesions found by this investigation will assist in creation of a differential

274

diagnosis when such a patient is encountered in clinic, prior to any surgical intervention or

275

pathology results. This information not only will facilitate development of an informed

276

differential diagnosis, but will also aid in initiating a logical route of continued non-invasive

277

work-up in at least a subset of these patients, justifying the use of different imaging modalities.

278

Although the frequency of mediastinal lesions has been studied in the past, the results

279

were conflicting for reasons that were mentioned earlier. It is difficult to compare our findings to

280

previous studies, as these were usually based solely on pathologic and/or surgical databases,

281

were small in size and from a single institution, and/or included cases without a final diagnosis.

282

An example as to how differences between studies substantially affect the distribution of certain

283

entities is reflected by the occurrence of a benign mediastinal cyst. In our study based on

284

radiology databases, benign mediastinal cysts were quite common; in fact, benign cysts were the

285

second most common mediastinal lesions (20.0%, after thymomas). They were the most

286

common lesions in the visceral mediastinum (16.8%), and the second most common lesions both

287

in the prevascular mediastinum (24.0%, after thymomas) and in the paravertebral mediastinum

288

(13.9%, after neurogenic tumors). Therefore, benign mediastinal cysts should be placed high on

289

the differential diagnostic list of mediastinal lesions. Similar to our study, in a study from Duke

290

University Medical Center which included 400 consecutive patients with primary mediastinal

291

lesions, all with a pathology diagnosis, 25% of patients were found to have cysts.[9] In contrast,

292

a surgical study of 37 solitary mediastinal masses found only 5 cysts (13.5%) which were

293

comprised of 3 patients with bronchogenic cysts and 2 patients with thymic cysts.[7] It is not

294

surprising that this study had a lower percentage of mediastinal cysts, as it was based on patients

295

who underwent surgical intervention. Knowing that these differences may be reflective of a

296

selection bias of a surgically treated cohort of patients as opposed to our cohort, which was based

297

on imaging studies, it is interesting when compared to two screening CT studies.[2, 3] The study

298

that aimed at screening for lung cancer[3] identified most (41 of 71 cases, 58%) mediastinal

299

lesions as “thymic masses”. Similar to our results, the vast majority of the “thymic masses” (39

300

of 41, 95%) were located in the “anterior” (prevascular) mediastinum. In that study, only 1 of the

301

41 thymic masses was identified as a cyst, 4 were found to be thymomas and 1 was diagnosed as

302

thymic carcinoma. However, in 35 patients with a “thymic mass” a specific diagnosis was not

303

made, and therefore a comparison to our study was difficult. However, in the more recent

304

screening study, which included both smokers and never-smokers, a much greater proportion of

305

benign prevascular cysts was found, more similar to our study. Of the 413 prevascular lesions

306

identified in the screening study, 50 were excised and 12 (24%) were malignant including 11

307

thymic epithelial tumors and 1 non-small-cell lung cancer. The majority of the resected lesions,

308

36 of 50 (72%), were benign cysts. Of these, 32 (89%) were thymic cysts and 4 (11%) were

309

duplication cysts. However, these results are difficult to compare to our study as the majority of

310

the lesions in this study, 362 of 413 prevascular lesions (88%), remained of unknown

311

etiology.[2] Furthermore, our data might be skewed as the majority of thymic cysts were

312

contributed from China. In fact the cohort of mediastinal lesions from China was comprised of

313

significantly more benign cysts (35.5% of all mediastinal lesions) than cohorts from Europe

314

(10.9%), Israel (10.3%), and North America (9.2%). The reason for this difference is not entirely

315

clear and might reflect, at least in part, a selection bias. This is further supported by a previous,

316

albeit much smaller, cohort of patient with mediastinal lesions from a different institution in

317

China that was identified by imaging studies and medical and surgical records and that was

318

comprised only to 15.8% of benign cysts.[17] Furthermore, conceivably, exposures and/or

319

genetic differences might also play a role. However, we did not analyze ethnicity of our study

320

cohort; therefore, these arguments are rather speculative.

321

These conflicting study results regarding the frequency of benign mediastinal cysts is of

322

no surprise, and may in fact reflect the increased use of MRI for thoracic imaging, which has

323

been increasingly recognized for its value.[18] Interestingly, MRI was most commonly used in

324

China (5.4% of all studies) which might, at least partially, explain the relatively high percentage

325

of benign mediastinal cysts in the Chinese cohort. It has been shown that benign mediastinal

326

cysts can be misinterpreted as solid on CT when they are of soft tissue attenuation on account of

327

proteinaceous or hemorrhagic content (up to 97 Hounsfield Units) despite containing fluid alone,

328

which has led in the past to unnecessary surgical resection.[2, 19] It could be that many of the

329

undiagnosed mediastinal masses found in screening for lung cancer patients[3] may have

330

represented such high attenuation cysts. It is possible that the occurrence of mediastinal cysts is

331

far higher than that suggested by our investigation, given the not infrequent under-recognition on

332

CT and the continued underutilization of MRI in many parts of the world. The fact that the use

333

of MRI imaging for chest evaluation has been lagging behind other parts of the body, is only in

334

part due to the motion artifacts inherit to the chest. These artifacts can be overcome with

335

different techniques routinely used today. Reaching clinical decisions by CT images alone,

336

without using MRI, has resulted in many unnecessary surgical procedures for benign disease.[19]

337

The increased use of MRI for evaluation of mediastinal masses is most pronounced in large

338

medical centers, where some clinicians and radiologists with a specific interest in thymomas and

339

MRI, work. Indeed, we noted higher utilization rates of thoracic MRI in larger medical centers as

340

compared to smaller hospitals (4.8% vs 1.8%, respectively). Another explanation might be that

341

MRI scanners are more numerous and more readily accessible in larger centers. Our findings

342

further emphasize that single institution studies might harbor a bias for certain mediastinal

343

lesions, depending on the size of the hospital.

344

We also showed that the occurrence of mediastinal lesions differs with age. For instance,

345

while thymomas, thymic carcinomas, benign cysts, metastases and small cell carcinomas were

346

more commonly identified in patients 50 years and older, lymphomas, germ cell tumors and

347

neurogenic tumors were more often found in patients younger than 50 years old. In fact,

348

lymphomas and germ cell tumors were most commonly seen in patients who were less than 30

349

years old. These findings confirmed previous observations that show median ages of 56[20] and

350

59.6[21] years for thymomas and thymic carcinomas, respectively but a mean age of 29

351

years[22] for mediastinal germ cell tumors.

352

In an attempt to analyze whether certain mediastinal lesions are more commonly seen in

353

larger hospitals, we stratified our results based on the number of beds. As mediastinal lesions are

354

overall rare, it was not surprising that most patients were contributed from larger hospitals with

355

more than 600 beds. None of the participating institutions had less than 300 beds. While this

356

could reflect participation bias, it might also show that these patients were commonly referred to

357

larger hospitals with more expertise in treating these patients.

358

We also showed that the frequency of mediastinal lesions differs depending on the

359

region. While in our study the most common mediastinal lesions overall were thymomas,

360

lymphomas were actually the predominant lesions amongst cases contributed from North

361

America (25.5%) and Israel (24.1%). Furthermore, in China, the relative number of prevascular

362

lesions (83.5%) was higher than in Europe (62.5%), North America (60.8%), and Israel (51.7%),

363

while visceral lesions were much less common in China (5.2%) than in Israel (26.4%), Europe

364

(21.9%) or North America (17.8%). While these findings might be due to referral bias, as all of

365

the cases from China and Israel were contributed from a single hospital, respectively, ethnic

366

differences might also play a role. For instance a study including immigrants with myasthenia

367

gravis in northern Europe showed that myasthenia gravis with thymoma was more frequent in

368

Asian myasthenia gravis immigrants compared with immigrants from Europe and South

369

America.[23] That study concluded that Asian immigrants (in that study from Indonesia, China,

370

Thailand, Vietnam, India, Turkey, Iran, Iraq, and Pakistan) with myasthenia gravis might carry

371

genetic factors or environmental/lifestyle factors that contribute to their specific phenotype.

372

However, we have not collected data specifically on ethnicity from our patients, therefore, a firm

373

conclusion with regards to differences in the frequency of mediastinal lesions based on ethnicity

374

cannot be drawn from our results.

375

While some studies of the incidence of mediastinal lesions avoid the inclusion of

376

lymphomas, our study indicated that lymphomas can occur as a newly diagnosed, single, discrete

377

lesion in the mediastinum. This of course was not reflected in lung cancer screening studies, as

378

such patients do not meet the criteria of inclusion for lung cancer screening studies.[3] Our data

379

highlighted that lymphomas need to be considered in the differential diagnosis of solitary

380

mediastinal lesions. In fact, we showed that lymphomas are the third most common lesion in the

381

mediastinum (16.1%) and although lymphomas can occur in any compartment, these tumors

382

were most often found in the prevascular mediastinum (14.4%) where they represented the third

383

most common lesion after thymomas and benign cysts. Interestingly, lymphomas were most

384

commonly identified in patients from North America (25.5%), followed by Israel (24.1%) and

385

Europe (16.6%) and only 4.9% of all patients from China had lymphomas. Again, the reason for

386

that difference is not clear, and we did not check ethnicity of patients in our study. However, it is

387

known that there are global variations in the incidence of lymphoma. For example, there are

388

marked variations in the incidence rates of NHL in various world regions with Israel Jews having

389

the highest incidence rate of NHL followed by Australia, USA whites, Canada, and Portugal in a

390

recent study of 185 countries using the GLOBOCAN database.[24]

391

There are limitations to our study. (i) Although our study is a multi-institutional,

392

international effort, it solely gathered data from China, Israel, Europe and North America, and

393

lacked contributions from South America, Africa and Australia. Furthermore, a large variety of

394

ethnic groups exist within some of the hospitals studied, in particularly in Europe and North

395

America which could not be assessed due to the retrospective nature of the study. (ii) While over

396

two-thirds of cases had a diagnosis established by pathology, a diagnosis of the remaining

397

patients was established based on imaging investigation and follow-up. (iii) Only lymphomas

398

that presented as a single dominant mediastinal lesion were included, however, conceivably,

399

some of these could have presented as mediastinal involvement by a systemic disease, in a region

400

not included in the imaging study. (iv) The search was performed using the aforementioned 4

401

broad search criteria. The use of these mandated search terms instead of a the refined word

402

search to report lesions may have caused some lesions to escape detection. However, as

403

identified during the pilot study, using refined search terms would have been impractical. (v).

404

While medical records were reviewed for follow-up information and pathology reports,

405

techniques that were used to retrieve the tissue such as FNA, core biopsies or resection was not

406

noted. Therefore, it is difficult to estimate whether potentially pathologic diagnoses could have

407

been missed due to sampling bias in FNAs and core biopsies.

408

Taken together, our multi-institutional, international study of solitary mediastinal lesions

409

based on radiology databases provides an important reference for the frequency and distribution

410

of mediastinal lesions identified on cross-sectional imaging including variance with patient age

411

and geographic region. This information is important when considering the differential diagnosis

412

of a specific patient.

413 414

References

415 416

1.

417 418

Study: Prevalence and CT Image Characteristics. Eur J Radiol Open 2015, 2:26-31. 2.

419 420

Araki T, Nishino M, Gao W, et al: Anterior Mediastinal Masses in the Framingham Heart

Yoon SH, Choi SH, Kang CH, Goo JM: Incidental Anterior Mediastinal Nodular Lesions on Chest CT in Asymptomatic Subjects. J Thorac Oncol 2018, 13:359-366.

3.

Henschke CI, Lee IJ, Wu N, Farooqi A, Khan A, Yankelevitz D, Altorki NK: CT

421

screening for lung cancer: prevalence and incidence of mediastinal masses. Radiology

422

2006, 239:586-590.

423

4.

de Jong WK, Blaauwgeers JL, Schaapveld M, Timens W, Klinkenberg TJ, Groen HJ:

424

Thymic epithelial tumours: a population-based study of the incidence, diagnostic

425

procedures and therapy. Eur J Canc 2008, 44:123-130.

426

5.

Adegboye VO, Brimmo AI, Adebo OA, Ogunseyinde OO, Obajimi MO: The place of

427

clinical features and standard chest radiography in evaluation of mediastinal masses.

428

West Afr J Med 2003, 22:156-160.

429

6.

430 431

Presentation of primary mediastinal masses in Ibadan. East Afr Med J 2003, 80:484-487. 7.

432 433

Adegboye VO, Ogunseyinde AO, Obajimi MO, Ogunbiyi O, Brimmo AI, Adebo OA:

Alizzi AM, Hemli JM, Diqer AM, Bidstrup B: Primary solitary mediastinal mass lesions: a review of 37 cases. Heart Lung Circ 2006, 15:310-313.

8.

Azarow KS, Pearl RH, Zurcher R, Edwards FH, Cohen AJ: Primary mediastinal masses.

434

A comparison of adult and pediatric populations. J Thorac Cardiovasc Surg 1993,

435

106:67-72.

436

9.

Davis RD, Jr., Oldham HN, Jr., Sabiston DC, Jr.: Primary cysts and neoplasms of the

437

mediastinum: recent changes in clinical presentation, methods of diagnosis, management,

438

and results. Ann Thorac Surg 1987, 44:229-237.

439

10.

440 441

of bronchogenic cysts between adults and children. J Pediatr Surg 2015, 50:399-401. 11.

442 443

12.

448

Petersdorf s: Mediastinal lymphomas. In Mediastinal Tumors: Update 1995. Edited by Wood de, Thomas CRJ. New York: Springer-Verlag; 1995

13.

446 447

Rubush JL, Gardner IR, Boyd WC, Ehrenhaft JL: Mediastinal tumors. Review of 186 cases. J Thorac Cardiovasc Surg 1973, 65:216-222.

444 445

Jiang JH, Yen SL, Lee SY, Chuang JH: Differences in the distribution and presentation

Johnson DW, Hoppe RT, Cox RS, Rosenberg SA, Kaplan HS: Hodgkin's disease limited to intrathoracic sites. Cancer 1983, 52:8-13.

14.

Levitt LJ, Aisenberg AC, Harris NL, Linggood RM, Poppema S: Primary non-Hodgkin's lymphoma of the mediastinum. Cancer 1982, 50:2486-2492.

449

15.

450 451

Primary mediastinal lymphoma in adults. Am J Med 1980, 68:509-514. 16.

452 453

Lichtenstein AK, Levine A, Taylor CR, Boswell W, Rossman S, Feinstein DI, Lukes RJ:

Carter BW, Tomiyama N, Bhora FY, et al: A modern definition of mediastinal compartments. J Thorac Oncol 2014, 9:S97-101.

17.

Liu T, Al-Kzayer LFY, Xie X, Fan H, Sarsam SN, Nakazawa Y, Chen L: Mediastinal

454

lesions across the age spectrum: a clinicopathological comparison between pediatric and

455

adult patients. Oncotarget 2017, 8:59845-59853.

456

18.

Ackman JB, Gaissert HA, Lanuti M, Digumarthy SR, Shepard JA, Halpern EF, Wright

457

CD: Impact of Nonvascular Thoracic MR Imaging on the Clinical Decision Making of

458

Thoracic Surgeons: A 2-year Prospective Study. Radiology 2016, 280:464-474.

459

19.

Ackman JB, Verzosa S, Kovach AE, Louissaint A, Jr., Lanuti M, Wright CD, Shepard

460

JA, Halpern EF: High rate of unnecessary thymectomy and its cause. Can computed

461

tomography distinguish thymoma, lymphoma, thymic hyperplasia, and thymic cysts? Eur

462

J Radiol 2015, 84:524-533.

463

20.

Roden AC, Yi ES, Jenkins SM, et al: Modified Masaoka stage and size are independent

464

prognostic predictors in thymoma and modified Masaoka stage is superior to

465

histopathologic classifications. J Thorac Oncol 2015, 10:691-700.

466

21.

Roden AC, Yi ES, Cassivi SD, Jenkins SM, Garces YI, Aubry MC: Clinicopathological

467

features of thymic carcinomas and the impact of histopathological agreement on

468

prognostical studies. Eur J Cardiothorac Surg 2013, 43:1131-1139.

469

22.

Stang A, Trabert B, Wentzensen N, Cook MB, Rusner C, Oosterhuis JW, McGlynn KA:

470

Gonadal and extragonadal germ cell tumours in the United States, 1973-2007. Int J

471

Androl 2012, 35:616-625.

472

23.

473 474

Boldingh MI, Maniaol A, Brunborg C, et al: Prevalence and clinical aspects of immigrants with myasthenia gravis in northern Europe. Muscle Nerve 2016.

24.

Miranda-Filho A, Pineros M, Znaor A, Marcos-Gragera R, Steliarova-Foucher E, Bray F:

475

Global patterns and trends in the incidence of non-Hodgkin lymphoma. Cancer Causes

476

Control 2019, 30:489-499.

477 478 479 480

Figure Legends:

481

Figure 1:

482

compartments. “Other” compartments include lesions that were located in more than one

483

compartment including prevascular and visceral, visceral and paravertebral, prevascular, visceral

484

and paravertebral, and prevascular and paravertebral. Distribution of the most common

485

mediastinal lesions based on geographic areas (B) and age (C). “Other” diagnoses include all

486

diagnoses that are listed in Table 3 except thymoma, benign cyst, lymphoma, thymic carcinoma,

487

and metastasis.

488

Figure 2:

489

in a 53-year-old woman followed for a remote history of Hodgkin lymphoma. A. Contrast

490

enhanced chest CT at the level of the transverse aorta (A) demonstrates a heterogeneous mass

491

(M) in the prevascular mediastinum directly invading the superior vena cava (arrow). B. Fused

492

positron emission tomography–computed tomography (PET-CT) shows there is 68gallium-

493

labelled somatostatin analogue in the mass. C. Esophageal duplication cyst in a 62-year old

494

woman. Unenhanced chest CT shows a 3.7cm homogenous intermediate attenuation mass

495

(arrow) at the level of the left atrium (LA) abutting the esophagus (arrowhead). D. Schwannoma

A. Distribution of the most common mediastinal lesions throughout the different

Example of common mediastinal lesions. A, B. WHO type B2 stage III thymoma

496

in a 34-year old woman. T2 weighted MR image at the level of the sterno-clavicular joint (S)

497

shows a high intensity mass (M) in the paravertebral mediastinum extending into the

498

intervertebral neural foramina (arrow).

499 500

Acknowledgements: Dr. Anja C. Roden would like to thank Robert Dominick for his work on

501

the radiology database.

Table 1: Distribution of mediastinal lesions based on mediastinal compartment (N=3,308)

Mediastinal Compartment, N (%)a

Overall, N (%)

Prevascular

Visceral

Paravertebral

pValuee

N

%

N

%

N

%

N

%

Number of patients

3,308

2,310

446

180

Age in years, median (Q1, Q3)

54.0

54.0

60.0

50.0

(range)

(40.0, 65.0) (40.0, 64.1) (48.0, 70.0) (36.0, 61.0) (18-98)

Gender, maleb

<0.0001

(18-98)

(18-98)

1,676 50.7 1164 50.4 225 50.6

(18-89)

49.4

0.97

92.4 2145 92.9 407 91.3 165 91.7

0.45

89

Imaging modalityf CT

3058

MRI

150

4.5

97

4.2

22

4.9

12

6.7

PET-CT

96

2.9

66

2.9

17

3.8

3

1.7

Pathology diagnosis availablec

2256 68.3 1503 65.1 309 69.4 124 69.3

0.14

Mediastinal lesiond Thymoma

734

22.2

712 30.8

7

1.6

0

0.0

Benign cyst

661

20.0

553 24.0

75

16.8

25

13.9 <0.0001

Lymphoma

532

16.1

333 14.4

34

7.6

9

5.0

<0.0001

Thymic carcinoma

186

5.6

172

1

0.2

0

0.0

<0.0001

7.5

<0.0001

Metastasis

168

5.1

64

2.8

66

14.8

4

2.2

<0.0001

Neurogenic tumor

136

4.1

24

1.0

5

1.1

97

53.9

<0.0001

Germ cell tumor

134

4.1

116

5.0

1

0.2

2

1.1

<0.0001

Benign thyroid lesion

120

3.6

40

1.7

58

13.0

0

0.0

<0.0001

Thymic hyperplasia

91

2.8

90

3.9

0

0.0

0

0.0

<0.0001

Small cell carcinoma

67

2.0

10

0.4

32

7.2

0

0.0

<0.0001

Other

476

14.4

194

8.4

167 37.4

43

23.9

Institutions (by continent and in alphabetical order; size [300-600 beds vs

N

%

1,323

40.0

87

2.6

Hospices Civils de Lyon, France (300-600)

233

7.0

Hôpital Cochin, Paris, France (>600)

164

5.0

Università Degli Studi di Napoli Federico II, Napoli, Italy (>600)

24

0.7

Kingston General Hospital, Ontario, Canada (300-600)

94

2.8

Massachusetts General Hospital, Boston MA, USA (>600)

506

15.3

Mayo Clinic, Rochester MN, USA (>600)

293

8.9

MD Anderson Cancer Center, Houston TX, USA (>600)

337

10.2

NYU Langone Medical Center, New York NY, USA (>600)

120

3.6

Yale School of Medicine, New Haven CT, USA (>600)

127

3.8

>600 beds] is in parentheses) Asia Shanghai Chest Hospital, China (>600) Sheba Medical Center, Ramat Gan, Israel (>600) Europe

North America

Information not available in a2 cases, b1 case, c5 cases, d3 cases, ep-value reflects only difference between prevascular, visceral and paravertebral compartments, Fisher Exact test used for all pvalues except for age for which Kruskal Wallis test was used, f4 other modalities reported besides CT, MRI, PET; these modalities are not included in this table; fields in red mark the entity that is most common in the respective mediastinal compartment.

Table 2: Distribution of mediastinal lesions based on age (N=3,308) p-value a

Age Category (in years) 18-29 N

%b

N

Number of patients

30-39 N

401

Gender, malec

%

40-49 N

424

%

50-59 N

534

%

60-69 N

714

%

≥70 N

681

% 554

221

55.1

232

54.7

254

47.6

336

47.1

356

52.3

277

50

0.029

Mediastinal lesion, N (%)d Thymoma

734

29

7.3

62

14.7

122

22.9

194

27.2

177

26.0

150

27.1 <0.0001

Benign cyst

661

16

4.0

60

14.2

109

20.5

186

26.1

164

24.1

126

22.7 <0.0001

Lymphoma

532

176

44.0 122

28.8

87

16.3

53

7.4

51

7.5

43

7.8

<0.0001

Thymic carcinoma

186

12

3.0

22

5.2

27

5.1

49

6.9

51

7.5

25

4.5

0.020

Metastasis

168

7

1.8

18

4.3

27

5.1

37

5.2

41

6.0

38

6.9

0.012

Neurogenic tumor

136

20

5.0

25

5.9

22

4.1

33

4.6

25

3.7

11

2.0

0.044

Germ cell tumor

134

65

16.3

42

9.9

15

2.8

8

1.1

3

0.4

1

0.2

<0.0001

Benign thyroid lesion

120

1

0.3

3

0.7

9

1.7

23

3.2

33

4.8

51

9.2

<0.0001

Thymic hyperplasia

91

24

6.0

17

4.0

27

5.1

15

2.1

7

1.0

1

0.2

<0.0001

Small cell carcinoma

67

0

0.0

1

0.2

4

0.8

16

2.2

25

3.7

21

3.8

<0.0001

Other

476

50

12.5

51

12.0

84

15.7

100

14.0

104

15.3

87

15.7

a

Chi-Square test; bpercentages are based on column; Information not available in c1 case, d3 cases

Table 3: Distribution of mediastinal lesions based on geographic region (N=3,308) P-Valuea

Geographic region, N (%) China

Israel

N

%

Europe

N

%

N

North America %

N

%

Number of patients

1,323

87

421

1,477

Age in years, median (Q1, Q3) (range)

55.0

53.0

53.3

53.0

(42.0, 64.0)

(34.0, 67.0)

(36.2, 65.2)

(39.0, 66.0)

(18-98)

(21-98)

(18-97.1)

(18-95.9)

Gender, male, N (%)b

0.70

678

51.2

45

52.3

207

49.2

746

50.5

0.88

1250

94.5

75

86.2

400

95.0

1333

90.3

<0.0001

MRI

72

5.4

2

2.3

9

2.1

67

4.5

PET-CT

0

0

10

11.5

12

2.9

74

5.0

691

52.3

50

57.5

353

83.8

1162

78.9

Imaging Modality, N (%) CT

Pathology diagnosis available, N (%)c Mediastinal compartment, N (%)d

<0.0001

Prevascular

1105

83.5

45

51.7

263

62.5

897

60.8

<0.0001

Visceral

69

5.2

23

26.4

92

21.9

262

17.8

<0.0001

Paravertebral

84

6.3

1

1.1

29

6.9

66

4.5

0.02

Multiple compartmentsf

65

4.9

18

20.7

37

8.8

250

16.9

<0.0001

Thymoma

424

32.0

11

12.6

96

22.8

203

13.8

<0.0001

Benign cyst

470

35.5

9

10.3

46

10.9

136

9.2

<0.0001

Lymphoma

65

4.9

21

24.1

70

16.6

376

25.5

<0.0001

Thymic carcinoma

106

8.0

7

8.0

14

3.3

59

4.0

<0.0001

Metastasis

3

0.2

16

18.4

19

4.5

130

8.8

<0.0001

Neurogenic tumor

84

6.3

0

0

16

3.8

36

2.4

<0.0001

Germ cell tumor

72

5.4

1

1.1

8

1.9

53

3.6

0.003

Benign thyroid lesion

29

2.2

2

2.3

13

3.1

76

5.2

0.0004

Thymic hyperplasia

0

0

3

3.4

35

8.3

53

3.6

<0.0001

Small cell carcinoma

1

0.1

2

2.3

5

1.2

59

4.0

<0.0001

Mediastinal lesion, N (%)e

Other a

69

5.2

15

17.2

99

23.5

293

19.8

<0.0001

Fisher Exact or Chi-square test for all except age (Kruskal Wallis test); Information not available in b1 case, c5 cases, d2 cases, e3

cases; fMultiple compartments: Tumors that were present in more than one compartment. See supplement 1 for entire list of tumors; fields in red mark the entity that is most common in the respective mediastinal compartment.

Table 4: Distribution of mediastinal lesions based on size of hospital and type of institution (N=3,308) Size of hospital, N (%) N of Beds 300-600 N

>600 %

p-value

N

%

Number of patients

327

2,981

Age in years, median (Q1, Q3)

52.4

54.0

(34.0, 66.8)

(40.0, 65.0)

(18-97.1)

(18-98)

(range)

Gender, male, N (%)a

0.12e

154

47.1

1,522

51.1

0.18f

317

96.9

2741

91.9

0.011f

MRI

6

1.8

144

4.8

PET-CT

4

1.2

92

3.1

293

89.6

1963

66.0

<0.0001f

Prevascular

215

65.7

2095

70.3

0.10f

Visceral

55

16.8

391

13.1

0.073f

Paravertebral

28

8.6

152

5.1

0.014f

Multiple compartmentsh

29

8.9

341

11.4

Imaging modality, N (%)g CT

Pathology diagnosis available, N (%)b Mediastinal compartment, N (%)c

Mediastinal lesion, N (%)d Thymoma

75

22.9

659

22.1

0.73f

Benign cyst

28

8.6

633

21.3

<0.0001f

Lymphoma

72

22.0

460

15.4

0.0032f

Thymic carcinoma

6

1.8

180

6.0

0.0009f

Metastasis

5

1.5

163

5.5

0.0008f

Neurogenic tumor

8

2.4

128

4.3

0.14f

Germ cell tumor

9

2.8

125

4.2

0.24f

Benign thyroid lesion

14

4.3

106

3.6

0.53f

Thymic hyperplasia

18

5.5

73

2.5

0.0036f

Small cell carcinoma

2

0.6

65

2.2

0.060f

Others

90

27.5

386

12.9

Information not available in a1 case, b5 cases, c2 cases; d3 cases, eKruskal Wallis test, fFisher Exact test, gOther imaging modality in 4 cases in institutions with >600 beds; hMultiple compartments: Tumors that were present in more than one compartment. See supplement 1 for entire list of tumors; fields in red mark the entity that is most common in the respective mediastinal compartment.